Effects of α1-acid glycoprotein fucosylation on its Ca2+ mobilizing capacity in neutrophils

Scandinavian Journal of Immunology

Volumn 69, Issue 5, 2009, Pages 412-420

  Levander, L ^a   Gunnarsson, P ^a   Grenegard M ^a   Ryden I ^b   Pahlsson P ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; EPITOPE; FUCOSE; GLYCOCONJUGATE; OLIGOSACCHARIDE; OROSOMUCOID; SIALIC ACID; SIALOPROTEIN; SIALYL LEWIS X ANTIGEN; 5 ACETYLNEURAMINYL (2 3) GALACTOSYL (1 4) (FUCOPYRANOSYL (1 3)) N ACETYLGLUCOSAMINE; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; FUCOSYLTRANSFERASE; FUT6 PROTEIN, HUMAN;

ARTHRITIS; ARTICLE; CALCIUM MOBILIZATION; CARBOHYDRATE ANALYSIS; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; FUCOSYLATION; HUMAN; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE FUNCTION; NEUTROPHIL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SIALYLATION; BLOOD; CHRONIC DISEASE; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM;

ARTHRITIS; CALCIUM; CHRONIC DISEASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUCOSE; FUCOSYLTRANSFERASES; NEUTROPHILS; OLIGOSACCHARIDES; OROSOMUCOID;

EID: 64549104286     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02240.x     Document Type: Article

References (38)

1. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 1999 19 : 203 14.
2. Schmid K. Human plasma alpha 1-acid glycoprotein - biochemical properties, the amino acid sequence and the structure of the carbohydrate moiety, variants and polymorphism. Prog Clin Biol Res 1989 300 : 7 22.
3. Fournier T, Medjoubi NN, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta 2000 1482 : 157 71.
4. Mackiewicz A, Pawlowski T, Mackiewicz-Pawlowska A, Wiktorowicz K, Mackiewicz S. Microheterogeneity forms of alpha 1-acid glycoprotein as indicators of rheumatoid arthritis activity. Clin Chim Acta 1987 163 : 185 90.
5. van Dijk W, Havenaar EC, Brinkman-van der Linden EC. Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Glycoconj J 1995 12 : 227 33.
6. Moule SK, Peak M, Thompson S, Turner GA. Studies of the sialylation and microheterogeneity of human serum alpha 1-acid glycoprotein in health and disease. Clin Chim Acta 1987 166 : 177 85.
7. Pawlowski T, Mackiewicz A, Mackiewicz S. Studies on microheterogeneity of acute-phase proteins in rheumatoid arthritis by using crossed affinoimmuno-electrophoresis with free concanavalin A. Behring Inst Mitt 1986 80 : 11 5.
8. De Graaf TW, Van der Stelt ME, Anbergen MG, van Dijk W. Inflammation-induced expression of sialyl Lewis x-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 1993 177 : 657 66.
9. Brinkman-Van der Linden CM, Havenaar EC, Van Ommen CR, Van Kamp GJ, Gooren LJ, Van Dijk W. Oral estrogen treatment induces a decrease in expression of sialyl Lewis x on alpha 1-acid glycoprotein in females and male-to-female transsexuals. Glycobiology 1996 6 : 407 12.
10. Havenaar EC, Axford JS, Brinkman-van der Linden EC et al. Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein. Glycoconj J 1998 15 : 723 9.
11. Ryden I, Skude G, Lundblad A, Pahlsson P. Glycosylation of alpha1-acid glycoprotein in inflammatory disease: analysis by high-pH anion-exchange chromatography and concanavalin A crossed affinity immunoelectrophoresis. Glycoconj J 1997 14 : 481 8.
12. Ryden I, Pahlsson P, Lundblad A, Skogh T. Fucosylation of alpha1-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis. Clin Chim Acta 2002 317 : 221 9.
13. Hochepied T, Berger FG, Baumann H, Libert C. Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 2003 14 : 25 34.
14. Hochepied T, Van Molle W, Berger FG, Baumann H, Libert C. Involvement of the acute phase protein alpha 1-acid glycoprotein in nonspecific resistance to a lethal gram-negative infection. J Biol Chem 2000 275 : 14903 9.
15. Kuebler JF, Toth B, Yokoyama Y, Bland KI, Rue LW, Chaudry IH. Alpha1-acid-glycoprotein protects against trauma-hemorrhagic shock. J Surg Res 2004 119 : 21 8.
16. Williams JP, Weiser MR, Pechet TT, Kobzik L, Moore FD Jr., Hechtman HB. Alpha 1-acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat. Am J Physiol 1997 273 : G1031 5.
17. Costello MJ, Gewurz H, Siegel JN. Inhibition of neutrophil activation by alpha1-acid glycoprotein. Clin Exp Immunol 1984 55 : 465 72.
18. Laine E, Couderc R, Roch-Arveiller M, Vasson MP, Giroud JP, Raichvarg D. Modulation of human polymorphonuclear neutrophil functions by alpha 1-acid glycoprotein. Inflammation 1990 14 : 1 9.
19. Vasson MP, Roch-Arveiller M, Couderc R, Baguet JC, Raichvarg D. Effects of alpha-1 acid glycoprotein on human polymorphonuclear neutrophils: influence of glycan microheterogeneity. Clin Chim Acta 1994 224 : 65 71.
20. 2+ in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (siglecs). FASEB J 2007 21 : 4059 69.
21. Angata T, Hayakawa T, Yamanaka M, Varki A, Nakamura M. Discovery of siglec-14, a novel sialic acid receptor undergoing concerted evolution with siglec-5 in primates. FASEB J 2006 20 : 1964 73.
22. Cornish AL, Freeman S, Forbes G et al. Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to cd33. Blood 1998 92 : 2123 32.
23. Brinkman-Van der Linden EC, Varki A. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-tn epitope. Sialic acid-binding immunoglobulin superfamily lectins. J Biol Chem 2000 275 : 8625 32.
24. Birkenmeier G, Kopperschlager G. Application of dye-ligant chromatography to the isolation of alpha-1-proteinase inhibitor and alpha-1-acid glycoprotein. J Chromatogr 1982 235 : 237 48.
25. Azzimonti F, Atchley DH, Morrison CA et al. One step purification of alpha(1)-acid glycoprotein from human plasma. Fractionation of its polymorphic allele products. J Chromatogr B Analyt Technol Biomed Life Sci 2003 784 : 33 8.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage t4. Nature 1970 227 : 680 5.
27. Olausson J, Tibell L, Jonsson BH, Pahlsson P. Detection of a high affinity binding site in recombinant Aleuria aurantia lectin. Glycoconj J 2008 25 : 753 62.
28. Ryden I, Lundblad A, Pahlsson P. Lectin ELISA for analysis of alpha(1)-acid glycoprotein fucosylation in the acute phase response. Clin Chem 1999 45 : 2010 2.
29. Sawardeker JS, Sloneker JH, Jeanes AR. Quantitative determination of monosaccharides as their alditol acetates by gas-liquid chromatography. Anal Chem 1965 37 : 1602 4.
30. Boyum A. Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest Suppl 1968 97 : 7.
31. Yoshima H, Matsumoto A, Mizuochi T, Kawasaki T, Kobata A. Comparative study of the carbohydrate moieties of rat and human plasma alpha 1-acid glycoproteins. J Biol Chem 1981 256 : 8476 84.
32. Brinkman-Van der Linden EC, Mollicone R, Oriol R, Larson G, Van den Eijnden DH, Van Dijk W. A missense mutation in the FUT6 gene results in total absence of alpha3-fucosylation of human alpha1-acid glycoprotein. J Biol Chem 1996 271 : 14492 5.
33. Shiyan SD, Bovin NV. Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha1-acid glycoprotein. Glycoconj J 1997 14 : 631 8.
34. Treuheit MJ, Costello CE, Halsall HB. Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein. Biochem J 1992 283 (Pt 1 105 12.
35. Spik G, Bayard B, Fournet B, Strecker G, Bouquelet S, Montreuil J. Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett 1975 50 : 296 9.
36. Spik G, Debruyne V, Montreuil J, van Halbeek H, Vliegenthart JF. Primary structure of two sialylated triantennary glycans from human serotransferrin. FEBS Lett 1985 183 : 65 9.
37. Poland DC, Garcia Vallejo JJ, Niessen HW et al. Activated human PMN synthesize and release a strongly fucosylated glycoform of alpha1-acid glycoprotein, which is transiently deposited in human myocardial infarction. J Leukoc Biol 2005 78 : 453 61.
38. Theilgaard-Monch K, Jacobsen LC, Rasmussen T et al. Highly glycosylated alpha1-acid glycoprotein is synthesized in myelocytes, stored in secondary granules, and released by activated neutrophils. J Leukoc Biol 2005 78 : 462 70.